Funds and ETFs J. B. Chemicals & Pharmaceuticals Limited

Equities

JBCHEPHARM

INE572A01036

Pharmaceuticals

Delayed Bombay S.E. 04:03:55 2024-04-29 am EDT 5-day change 1st Jan Change
1,891 INR +1.42% Intraday chart for J. B. Chemicals & Pharmaceuticals Limited +5.91% +16.46%

ETFs positioned on J. B. Chemicals & Pharmaceuticals Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.14% -
0.00% 117 M€ +1.11% -
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,864 INR
Average target price
1,882 INR
Spread / Average Target
+0.95%
Consensus
  1. Stock Market
  2. Equities
  3. JBCHEPHARM Stock
  4. Funds and ETFs J. B. Chemicals & Pharmaceuticals Limited